MLAB Mesa Laboratories Inc.

Mesa Labs Releases Second Annual Responsible Business Program Brochure

Mesa Labs Releases Second Annual Responsible Business Program Brochure

LAKEWOOD, Colo, March 15, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB, “Mesa” “we” “our” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced the release of its . Rooted in Mesa’s unwavering commitment to Protecting the Vulnerable®, this brochure highlights the Company’s continued strides in environmental stewardship, social responsibility, and corporate governance.

The latest edition of Mesa’s ESG Program Brochure is marked by two updates from the past fiscal year, signifying a new chapter in the Company’s sustainability journey. In October 2023, Mesa acquired GKE, a German-based sterilization indicators business renowned for its robust organizational culture dedicated to positively impacting the environment. This strategic addition aligns seamlessly with Mesa’s mission and expands the Company’s global footprint while contributing to a sustainable future.

Notably, Mesa has further fortified its commitment to transparency and environmental responsibility by incorporating greenhouse gas emissions Scope 1 and 2 data into the brochure. This comprehensive approach underscores Mesa’s dedication to addressing climate change and ensuring accountability in its operations.

"Companies should be a net positive for the world. Our purpose of Protecting the Vulnerable® extends beyond our focus on improving patient care. Often susceptible to harm and inequalities, the vulnerable also includes our employees, the communities where we operate, and the earth that must be preserved for generations to come. To truly fulfill our purpose, our processes and activities should be managed in a sustainable manner," emphasized Gary Owens, President, and Chief Executive Officer of Mesa.

Mesa’s commitment to environmental sustainability, people and communities, and corporate governance is deeply ingrained in its corporate culture, starting from a Board of Directors that sets the tone for responsible business practices. The Company’s ESG Taskforce, comprising cross-functional leaders, propels Mesa forward in its initiatives, ensuring a comprehensive and impactful approach.

The second annual ESG Program Brochure builds on the success of the inaugural edition, offering stakeholders a qualitative glimpse into Mesa’s journey toward sustainability. By Protecting the Vulnerable® not only through innovative life science tools but also through responsible corporate practices, Mesa Laboratories stands at the forefront of positive global change.

For more information, download the Fiscal Year 2025 Environmental, Social, and Governance Program Brochure on Mesa’s website at .

About Mesa Laboratories, Inc.

Mesa is a multinational leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Safe Harbor Statement

This document, including the letter above from our CEO, contains forward-looking statements within the meaning of federal securities laws. All statements other than statements of historical or current facts, including statements regarding our environmental and other sustainability plans and goals, made in this document are forward-looking. We use words such as “expect,” “seek,” “anticipate,” “intend,” “plan,” “believe,” “could,” “should,” “estimate,” “may,” “target,” “project,” and similar expressions to identify forward-looking statements.  However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements are made based on expectations and beliefs concerning future events affecting us and are subject to risks and uncertainties relating to our operations and business environments, all of which are difficult to predict and many of which are beyond our control, that could cause our actual results to differ materially from those matters expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended March 31, 2022, and those described from time to time in our subsequent reports filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this brochure and except to the extent required by applicable law, the Company does not assume any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise. Mesa does not give any assurance that it will achieve its expectations. Website references throughout this document are provided for convenience only, and the content on the referenced websites is not incorporated by reference into this document.

For more information about the Company, please visit its website at 






Contact Data
CONTACT: Gary Owens.; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc.,  
EN
15/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mesa Laboratories Inc.

 PRESS RELEASE

Mesa Laboratories Executes Previously-Announced Strategic Financing Pl...

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company’s 1.375% Convertible Senior Notes due August 2025 (the “2025 Notes”). On August 12, 2025, the Company drew $97.0 million under its existing Amended and Restated Credit Agreement (the “Credit Agreement”), bringing the total outstanding balance to $108...

 PRESS RELEASE

Mesa Labs Announces First Quarter Results

Mesa Labs Announces First Quarter Results LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q26”) ended June 30, 2025 (amounts in thousands). First quarter FY26 compared to first quarter FY25: Revenues increased 2.4%Non-GAAP core organic revenues1 growth was 0.4% Operating income decreased 45.1% to $3,064 primarily due to the impacts of FX and non-cash stock-based compensation ...

 PRESS RELEASE

MESA LABS DECLARES QUARTERLY DIVIDEND

MESA LABS DECLARES QUARTERLY DIVIDEND LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the p...

 PRESS RELEASE

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5,...

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025 LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and servic...

 PRESS RELEASE

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q25”) and full fiscal year (“FY25”) ended March 31, 2025 (amounts in thousands). Fourth quarter FY25 compared to fourth quarter FY24: Revenues increased 5.5%Non-GAAP core organic revenues growth1 was 6.3%Operating income increased 100.5% to $1,469Non-GAA...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch